FI911718L - 3,5-disubstituerade 2-isoxazoliner och isoxazoler, foerfaranden foer framstaellning av dem, laekemedel innehaollande dessa samt deras anvaendning. - Google Patents

3,5-disubstituerade 2-isoxazoliner och isoxazoler, foerfaranden foer framstaellning av dem, laekemedel innehaollande dessa samt deras anvaendning. Download PDF

Info

Publication number
FI911718L
FI911718L FI911718A FI911718A FI911718L FI 911718 L FI911718 L FI 911718L FI 911718 A FI911718 A FI 911718A FI 911718 A FI911718 A FI 911718A FI 911718 L FI911718 L FI 911718L
Authority
FI
Finland
Prior art keywords
isoxazoliner
isoxazoler
disubstituerade
laekemedel
dem
Prior art date
Application number
FI911718A
Other languages
English (en)
Finnish (fi)
Other versions
FI911718A7 (fi
FI911718A0 (fi
Inventor
Wilfried Schwab
Hiristo Anagnostopulos
Elena Porsche-Wiebking
John Grome
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI911718A0 publication Critical patent/FI911718A0/fi
Publication of FI911718A7 publication Critical patent/FI911718A7/fi
Publication of FI911718L publication Critical patent/FI911718L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/653—Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FI911718A 1990-04-12 1991-04-10 3,5-disubstituerade 2-isoxazoliner och isoxazoler, foerfaranden foer framstaellning av dem, laekemedel innehaollande dessa samt deras anvaendning. FI911718L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4011880 1990-04-12

Publications (3)

Publication Number Publication Date
FI911718A0 FI911718A0 (fi) 1991-04-10
FI911718A7 FI911718A7 (fi) 1991-10-13
FI911718L true FI911718L (fi) 1991-10-13

Family

ID=6404301

Family Applications (1)

Application Number Title Priority Date Filing Date
FI911718A FI911718L (fi) 1990-04-12 1991-04-10 3,5-disubstituerade 2-isoxazoliner och isoxazoler, foerfaranden foer framstaellning av dem, laekemedel innehaollande dessa samt deras anvaendning.

Country Status (16)

Country Link
US (1) US5273989A (cs)
EP (1) EP0451790A1 (cs)
JP (1) JPH04234857A (cs)
KR (1) KR910018363A (cs)
CN (1) CN1055537A (cs)
AU (1) AU7428591A (cs)
BR (1) BR9101475A (cs)
CA (1) CA2040219A1 (cs)
CS (1) CS101391A2 (cs)
FI (1) FI911718L (cs)
HU (1) HU911183D0 (cs)
IE (1) IE911235A1 (cs)
IL (1) IL97821A0 (cs)
NO (1) NO911432L (cs)
PT (1) PT97329A (cs)
ZA (1) ZA912701B (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6115794A (en) * 1993-03-02 1994-09-26 Fujisawa Pharmaceutical Co., Ltd. Isoxazole derivative
ES2139754T3 (es) * 1993-11-26 2000-02-16 Pfizer 3-fenil-2-isoxazolinas como agentes antiinflamatorios.
ATE154932T1 (de) * 1993-11-26 1997-07-15 Pfizer Isoxazolinverbindungen als entzündungshemmende mittel
US5767118A (en) * 1994-10-26 1998-06-16 Merck & Co., Inc. 4-Heterocyclic peperidines promote release of growth hormone
FR2752163B1 (fr) * 1996-08-12 1998-10-30 Pf Medicament Utilisation de l'efaroxan pour la fabricaton de medicament destine au traitement de la maladie de huntington
KR19990011062A (ko) * 1997-07-21 1999-02-18 손욱 이소옥사졸리딘 고리 함유 액정화합물 및 이를 포함하고 있는 액정 조성물
US6319937B1 (en) * 1998-11-18 2001-11-20 Dupont Pharmaceuticals Company Isoxazoline fibrinogen receptor antagonists
MXPA02002578A (es) 1999-09-08 2002-10-23 Guilford Pharm Inc Compuestos de union a ciclofilina no peptidicos, y su uso.
CA2435829A1 (en) 2001-01-25 2002-08-01 Guilford Pharmaceuticals Inc. Trisubstituted carbocyclic cyclophilin binding compounds and their use
WO2003074501A1 (en) * 2002-03-07 2003-09-12 Sds Biotech K.K. Substituted isoxazole alkylamine derivative and agri- and horticultural fungicide
US7662771B2 (en) * 2003-08-20 2010-02-16 Emisphere Technologies, Inc. Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptide
DE602004006279T2 (de) * 2003-08-20 2007-12-27 Eli Lilly And Co., Indianapolis Verbindungen, verfahren und formulierungen zur oralen verabreichung einer glucagonartigen peptid (glp)-1-verbindung oder eines melanocortin-4-rezeptor-(mc4-)agonistschen peptids
CA2587224A1 (en) * 2004-11-19 2006-05-26 Plant Bioscience Limited Microcin b17 analogs and methods for their preparation and use
WO2008150487A2 (en) * 2007-05-31 2008-12-11 Texas Tech University Synthesis of half esters
US8765735B2 (en) * 2009-05-18 2014-07-01 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
US8927551B2 (en) * 2009-05-18 2015-01-06 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
US9149465B2 (en) * 2009-05-18 2015-10-06 Infinity Pharmaceuticals, Inc. Isoxazolines as inhibitors of fatty acid amide hydrolase
US10106509B2 (en) * 2015-02-27 2018-10-23 Op Bio Factory Co., Ltd. Method for producing kakeromycin and derivatives thereof
PL3538525T3 (pl) * 2016-11-08 2022-09-12 Bristol-Myers Squibb Company 3-podstawione kwasy propionowe jako inhibitory integryny alfa v
CN111333590B (zh) * 2018-12-18 2022-05-17 沈阳中化农药化工研发有限公司 一种异恶唑烷盐酸盐的制备方法
CN113149926B (zh) * 2021-04-30 2023-05-26 华侨大学 一种3,5-二取代异恶唑衍生物的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA826165A (en) * 1969-10-28 Gagneux Andre Process for the production of an isoxazole derivative
US3152139A (en) * 1961-10-17 1964-10-06 Geigy Chem Corp Certain aminoisoxazolone derivatives
CH450423A (de) * 1965-06-03 1968-01-31 Geigy Ag J R Verfahren zur Herstellung von 3-Hydroxy-5-aminomethyl-isoxazol
DK150615C (da) * 1982-10-26 1987-11-09 Cheminova As Fremgangsmaade til fremstilling af substituerede 3-isoxazololer
CA1261335A (en) * 1984-08-29 1989-09-26 Hoffmann-La Roche Limited/Hoffmann-La Roche Limitee Ethylenediamine monoamide derivatives
WO1988009330A1 (en) * 1987-05-20 1988-12-01 Zambon Group S.P.A. Isoxazoles with nootropic activity
DE3736113A1 (de) * 1987-10-26 1989-05-03 Hoechst Ag Arzneimittel, darin enthaltene phosphorhaltige 2-isoxazoline und isoxazole, sowie herstellungsverfahren fuer diese heterocyclischen verbindungen
DE3914969A1 (de) * 1989-05-02 1990-11-08 Schering Ag 5-substituierte 3-arylisoxazol-derivate, deren herstellung und verwendung als schaedlingsbekaempfungsmittel
JP2786683B2 (ja) * 1989-08-15 1998-08-13 三共株式会社 グリコール誘導体およびその用途

Also Published As

Publication number Publication date
KR910018363A (ko) 1991-11-30
FI911718A7 (fi) 1991-10-13
AU7428591A (en) 1991-10-17
NO911432L (no) 1991-10-14
ZA912701B (en) 1991-12-24
EP0451790A1 (de) 1991-10-16
IE911235A1 (en) 1991-10-23
CN1055537A (zh) 1991-10-23
BR9101475A (pt) 1991-11-26
PT97329A (pt) 1992-01-31
HU911183D0 (en) 1991-10-28
CA2040219A1 (en) 1991-10-13
IL97821A0 (en) 1992-06-21
US5273989A (en) 1993-12-28
NO911432D0 (no) 1991-04-11
JPH04234857A (ja) 1992-08-24
FI911718A0 (fi) 1991-04-10
CS101391A2 (en) 1991-11-12

Similar Documents

Publication Publication Date Title
FI912524A7 (fi) Pulverformigt, skummande vitgoeringsmedel foer kaffe, foerfarande och anordning foer framstaellning av detsamma samt pulverformig blandning foer framstaellning av detsamma samt pulverformig blandning foer framstaellning av kaffedrycker.
FI911070L (fi) Foerfarande foer framstaellning av skumplaster medelst anvaendning av drivgaser, vilka innehaoller fluoralkaner, och fluorerade etrar, samt enligt detta foerfarande framstaellda skumplaster.
FI915282A7 (fi) Mono-n-substituerade 1,4,7,10-tetra -azacyklododekanderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska aemnen.
FI911330L (fi) 1,4,7,10-tetra-azacyklododekan -butyltrioler, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska aemnen.
FI911718L (fi) 3,5-disubstituerade 2-isoxazoliner och isoxazoler, foerfaranden foer framstaellning av dem, laekemedel innehaollande dessa samt deras anvaendning.
FI905843A7 (fi) Foerfarande och anordning foer granskning av rakheten av hissgejder och foer raettande av avrikelser samt maetanordning.
FI911921A7 (fi) Synkronisationsfoerfarande foer sdh -system samt foerfarande och kopplingsanordning foer igenkaenning av olika datastrukturer.
FI905492A0 (fi) Mejeriprodukt samt foerfarande och anlaeggning foer framstaellning av denna.
FI904370A7 (fi) Foerfarande foer tillverkning av sandwichelement bestaoende av en kaerna av mineralullslameller och ytskikt exempelvis av plaot samt en anordning foer utfoerande av foerfarandet.
FI914487A0 (fi) 1,3-bensoxazinderivat, deras framstaellning och anvaendning.
FI930051L (fi) 4,13-dioxabicyklo(8.2.1)tridecenonderivat samt foerfarande och mellanprodukt foer deras framstaellning
FI913723L (fi) Dihydroxipropylsulfoetylcellulosor, framstaellning och anvaendning av dem.
FI902771A0 (fi) Foerfarande foer framstaellning av antiinflammatoriska 1,3,4-tiadiazoler och 1,3,4-oxadiazoler.
FI904281L (fi) Dynamiskt spaenningsintegreringsfoerfarande samt kopplingar foer utfoerande och tillaempande av foerfarandet.
FI913565A7 (fi) Substituerade fenylacetylenfoereningar, laekemedel innehaollande dem samt ett foerfarande foer framstaellning av dessa foereningar och laekemedel.
FI905395A0 (fi) Flerlagersmassivtraeprodukter, saosom balkar, braedor och limbindbalkar samt foerfarande foer framstaellning av dessa.
FI923458L (fi) 4,5-cykloalkano-3-benzazepin-7-ol- derivat och deras anvaendning.
FI905920A7 (fi) Foerfarande foer riktande av bergborranordningensmatarbalk samt bergborranordning och maetningsanordning.
FI911590A0 (fi) Oxidisk superledande traod, foerfarande foer framstaellning av samma samt foerfarande foer behandling av samma.
FI923763A0 (fi) Inklaednad av bergvaeggar saosom tunnlar och dylikt, samt saett foer att aostadkomma inklaednaden.
FI912872L (fi) Kristall av fluoranblandning, foerfarande foer framstaellning av naemnda kristall samt registreringsmaterial omfattande naemnda kristall.
FI915930L (fi) Nya 15-nitro-2b,3b-dihydro- och 15-nitro-2b,3b,6,7-tetrahydrotabersoninderivater, farmaceutiska sammansaettningar innehaollande dem och deras framstaellningsmetod.
FI916139L (fi) Fibermassekomponent foer framstaellning av papper, papper framstaellt daerav samt foerfarande foer framstaellning av fibermassekomponent och papper.
FI913066L (fi) Oxikloreringsfoerfarande och -katalysator och deras anvaendning foer framstaellning av 1,2-dikloretan.
FI900591A0 (fi) Apparatenhet foer fartyg, foerfarande foer apparatmontage samt formmedel foer tillverkning av flaensorgan.